Thousands of people in Britain are experiencing a puzzling and severe skin disorder that has stumped doctors. Sufferers experience their skin badly inflamed, cracked and flaking, commonly affecting large areas of their body, yet many doctors have trouble diagnosing or treating the condition. The condition, known as topical steroid withdrawal (TSW) or red skin syndrome, has created considerable interest on social media, with footage showing patients’ experiences receiving more than a billion views on TikTok alone. Despite affecting a increasing number of people, TSW remains so poorly understood that some general practitioners and dermatologists query whether it actually exists at all. Now, for the very first time, researchers across the UK are launching a large-scale study to examine what is behind these mysterious symptoms and reasons why some people develop the condition whereas others do not.
The Unexplained Illness Spreading Across the UK
Bethany Gamble’s case exemplifies the devastating impact of topical steroid withdrawal on sufferers’ lives. The 21-year-old from Birmingham had managed her eczema successfully with steroid creams since childhood, but at eighteen, her condition deteriorated significantly. Her skin became acutely inflamed with redness, cracking and oozing whilst the itching became what she describes as “bone deep”. Within two years, the pain had become so intense that she was confined to her bed, needing constant care from her mother. Most distressing of all, Bethany was repeatedly dismissed by doctors who blamed her symptoms on standard eczema and kept prescribing the very treatments she believed were causing her suffering.
The medical establishment is split on how to approach TSW, with deep divisions about its very nature. Some experts consider it a debilitating allergic reaction to the topical steroids that represent the standard treatment for eczema across the NHS. Others contend it represents a severe flare-up of current skin conditions rather than a separate syndrome, whilst a handful remain unconvinced of its existence altogether. This professional uncertainty has placed patients like Bethany caught in a diagnostic uncertainty, struggling to access suitable treatment. The lack of consensus has prompted Professor Sara Brown at the Edinburgh University to set up the first major UK research project studying TSW, funded by the National Eczema Society.
- Symptoms comprise significant swelling, cracking skin and intense itching throughout the body
- Patients describe “elephant skin” hardening and extreme shedding of keratinised cells
- Medical professionals often dismiss TSW as typical dermatitis or decline to recognise it
- The condition may become so incapacitating that sufferers become unable to perform daily activities
Living with Steroid Topical Withdrawal
From Mild Eczema to Disabling Symptoms
For numerous patients, topical steroid withdrawal represents a severe decline from a previously stable dermatological condition. What starts with occasional itching in skin creases can quickly progress into a full-body inflammatory response that renders patients unable to function. The transition often occurs suddenly, without warning, transforming a manageable chronic condition into an severe medical emergency. Patients report their skin becoming intensely hot, inflamed and red, with severe cracking and oozing that demands ongoing care. The bodily burden is worsened by exhaustion, as the persistent itching disrupts sleep and healing, creating a destructive cycle of decline.
The rate at which TSW develops catches many sufferers off guard. Those who have lived with eczema for years, sometimes decades, are unprepared for the magnitude of symptoms that emerge when their condition suddenly worsens. Everyday tasks become overwhelming difficulties: showering becomes agonising, dressing needs support, and maintaining personal hygiene demands substantial energy. Some patients report feeling as though their skin is being ravaged from within, with inflammation moving through their body in patterns that show little similarity to their previous eczema flare-ups. This striking change often leads sufferers to seek urgent medical help, only to encounter disbelief from healthcare professionals.
The Push for Recognition
Perhaps the most distressing aspect of topical steroid withdrawal is the dismissive medical responses that commonly occurs with it. Patients presenting with severe, unexplained symptoms are consistently informed they simply have eczema flaring up, despite their insistence that this is fundamentally different from anything they’ve encountered previously. Doctors often respond by recommending higher-strength steroids or increased doses, possibly exacerbating the very condition patients believe the creams caused. This cycle of dismissal leaves sufferers experiencing abandonment by the medical establishment, compelled to manage their illness alone whilst being informed that their personal experience lacks validity. Many patients report feeling gaslit repeatedly, their worries disregarded as anxiety or psychological rather than genuine physiological symptoms.
The absence of professional agreement has created a significant divide between what patients report and clinical acknowledgement. Without established diagnostic standards or defined treatment approaches, GPs and dermatologists struggle to identify TSW or offer appropriate support. Some practitioners remain entirely unconvinced the disorder is real, treating all acute cases as typical eczema or recognised skin disorders. This clinical doubt results in diagnostic delays, unsuitable therapies and significant emotional suffering for patients already suffering physically. The growing visibility of TSW on online platforms has highlighted this diagnostic gap, encouraging investigation to examine the experiences reported by vast numbers of individuals, even as the healthcare profession remains divided on how to respond.
- Signs may develop suddenly in individuals with previously stable eczema managed by topical steroids
- Patients often face scepticism from medical practitioners who ascribe deterioration to typical eczema exacerbations
- Medical professionals continue to disagree on whether TSW is a real disorder or acute eczema flare-up
- Absence of established diagnostic standards means numerous patients find it difficult to obtain suitable care and support
- Online platforms has magnified voices of patients, with TSW hashtags accumulating more than one billion views globally
Ethnic Inequalities in Assessment and Clinical Management
The diagnostic challenges surrounding topical steroid withdrawal become more acute amongst those with darker complexions, where symptoms can be substantially more challenging to detect visually. Redness and inflammation, the defining features of TSW in those with lighter complexions, appear differently across different ethnic groups, yet many assessment protocols remain focused on how the condition appears in white patients. This gap means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW commonly experience substantially longer periods in recognition and validation. Medical staff trained primarily on presentations in lighter skin may miss or misread the typical indicators, causing additional diagnostic errors and unsuitable therapeutic suggestions that can intensify distress.
Research into TSW has historically overlooked the lived experiences with darker complexions, sustaining a pattern where their symptoms remain insufficiently documented and inadequately researched. The social media conversations dominating TSW discussions have been predominantly influenced by voices with lighter skin, potentially skewing clinical knowledge and public awareness. As Professor Sara Brown’s groundbreaking UK study advances, ensuring diverse representation amongst participants will be crucial to developing truly inclusive diagnostic frameworks and therapeutic strategies. Without deliberate efforts to prioritise the perspectives of all ethnic groups, healthcare disparities in TSW recognition and management threaten to increase, abandoning at-risk communities without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Emerging Research and Care Approaches Developing
Initial Major UK Investigation In Progress
Professor Sara Brown’s pioneering research at the University of Edinburgh represents a watershed moment for TSW sufferers seeking validation and clarity. With backing from the National Eczema Society, the study has brought together numerous participants in the UK to examine the physiological processes behind topical steroid withdrawal. By assessing symptoms, saliva samples and skin biopsies, researchers hope to identify why particular individuals exhibit TSW whilst others on identical steroid regimens do not. This scientific scrutiny marks a notable change from dismissal to rigorous examination.
The research team partnering with Dr Alice Burleigh from advocacy group for patients Scratch That, brings both medical knowledge and lived experience to the study. Their joint methodology recognises that patients hold crucial insights into their conditions. Professor Brown has noted patterns in TSW that defy explanation by standard eczema knowledge, including marked “elephant skin” thickening, pronounced shedding and distinctly marked zones of inflammation. The research findings could fundamentally reshape how healthcare practitioners approach diagnosis and management of this debilitating condition.
Treatment Options and Associated Limitations
Currently, management options for TSW continue to be limited and frequently inadequate. Many healthcare professionals continue prescribing topical steroids despite clear evidence implying they might intensify symptoms in those predisposed. Some patients report temporary relief from emollients, antihistamines and systemic medications, though responses vary considerably. Dermatologists remain divided on best treatment approaches, with some supporting total steroid discontinuation whilst others suggest slow reduction. This lack of consensus sees patients managing their care journeys mostly in isolation, drawing substantially on peer support networks and online communities for advice.
Psychological support and specialist dermatological care may provide advantages, yet access is inconsistent across the NHS. Some patients have explored alternative approaches including dietary modifications, environmental controls and whole-person treatment approaches, though scientific evidence supporting these interventions remains sparse. The lack of established clinical protocols means treatment decisions often depend on individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research produces definitive answers, TSW sufferers frequently describe feeling abandoned by conventional medicine.
- Emollient creams and hydrating products to maintain skin barrier function and reduce water loss
- Antihistamines to alleviate pruritus and related sleep disruption in flare episodes
- Oral corticosteroids or immune-suppressing agents for serious presentations under specialist supervision
- Psychological counselling to address trauma and anxiety stemming from chronic skin conditions
Testimonies of Aspiration and Perseverance
Despite the uncertainty regarding TSW and the frequently dismissive perspectives from medical practitioners, patients are drawing strength in community and collective experience. Digital support communities have become lifelines for those struggling with the disorder, providing practical guidance and validation when traditional medicine has failed them. Many individuals affected describe the moment they discovered the TSW hashtag as pivotal—finally connecting with others with identical symptoms and realising they were not isolated in their suffering. This collective voice has been powerful enough to trigger the initial serious research initiatives, demonstrating that patient-led campaigns can drive medical progress even when established institutions remain sceptical.
Bethany Gamble and people in similar situations are committed to raise awareness and push for appropriate acknowledgement of TSW within the medical community. Their readiness to recount personal stories of their struggles on social media has made discussions more commonplace around a condition that many doctors still are unwilling to accept. These patients are not sitting idly for answers; they are actively participating in research studies, recording their manifestations carefully, and requiring that their accounts be treated with respect. Their resilience in the midst of ongoing pain and medical gaslighting provides encouragement that answers may finally be within grasp, and that upcoming sufferers will be given the validation and care they so desperately need.
- Patient-led research initiatives are addressing shortcomings left by traditional medical institutions and accelerating understanding of TSW
- Online communities offer emotional support, actionable management techniques, and mutual recognition for affected individuals globally
- Campaign work are gradually shifting clinical attitudes, prompting dermatologists to examine rather than dismiss patient concerns
